Sectoral Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,474
Closed -$380K 116
2023
Q4
$380K Sell
6,474
-175,430
-96% -$10.3M 0.16% 87
2023
Q3
$7.92M Buy
181,904
+33,351
+22% +$1.45M 1.54% 21
2023
Q2
$5.37M Buy
148,553
+20,147
+16% +$728K 0.89% 52
2023
Q1
$4.77M Buy
128,406
+61,560
+92% +$2.29M 0.92% 49
2022
Q4
$3.03M Buy
66,846
+7,330
+12% +$332K 0.59% 68
2022
Q3
$4.16M Sell
59,516
-9,097
-13% -$635K 0.82% 55
2022
Q2
$4.61M Buy
68,613
+8,776
+15% +$589K 0.93% 46
2022
Q1
$4.92M Sell
59,837
-16,000
-21% -$1.32M 0.87% 47
2021
Q4
$11.1M Buy
75,837
+73,286
+2,873% +$10.8M 1.67% 20
2021
Q3
$451K Buy
2,551
+120
+5% +$21.2K 0.04% 119
2021
Q2
$393K Sell
2,431
-76,650
-97% -$12.4M 0.03% 118
2021
Q1
$13.5M Buy
79,081
+5,443
+7% +$932K 1.03% 33
2020
Q4
$16.2M Buy
+73,638
New +$16.2M 1.14% 33
2020
Q3
Sell
-125,336
Closed -$14.3M 186
2020
Q2
$14.3M Buy
125,336
+51,236
+69% +$5.85M 1.31% 33
2020
Q1
$5.7M Buy
+74,100
New +$5.7M 1.09% 44